Development of Biphasic Injectable Hydrogels for Meniscus Scaffold from Photocrosslinked Glycidyl Methacrylate-Modified Poly(Vinyl Alcohol)/Glycidyl Methacrylate-Modified Silk Fibroin

Rachasit Jeencham,Jiraporn Sinna,Chaiwat Ruksakulpiwat,Tulyapruek Tawonsawatruk,Piya-on Numpaisal,Yupaporn Ruksakulpiwat
DOI: https://doi.org/10.3390/polym16081093
IF: 5
2024-04-15
Polymers
Abstract:The development of a hydrogel material with a modified chemical structure of poly(vinyl alcohol) (PVA) and silk fibroin (SF) using glycidyl methacrylate (GMA) (denoted as PVA-g-GMA and SF-g-GMA) is an innovative approach in the field of biomaterials and meniscus tissue engineering in this study. The PVA-g-GMA/SF-g-GMA hydrogel was fabricated using different ratios of PVA-g-GMA to SF-g-GMA: 100/0, 75/25, 50/50, 25/75, and 0/100 (w/w of dry substances), using lithium phenyl (2,4,6-trimethylbenzoyl)phosphinate (LAP) as a free radical photoinitiator, for 10 min at a low ultraviolet (UV) intensity (365 nm, 6 mW/cm2). The mechanical properties, morphology, pore size, and biodegradability of the PVA-g-GMA/SF-g-GMA hydrogel were investigated. Finally, for clinical application, human chondrocyte cell lines (HCPCs) were mixed into PVA-g-GMA/SF-g-GMA solutions and fabricated into hydrogel to study the viability of live and dead cells and gene expression. The results indicate that as the SF-g-GMA content increased, the compressive modulus of the PVA-g-GMA/SF-g-GMA hydrogel dropped from approximately 173 to 11 kPa. The degradation rates of PVA-g-GMA/SF-g-GMA 100/0, 75/25, and 50/50 reached up to 15.61%, 17.23%, and 18.93% in 4 months, respectively. In all PVA-g-GMA/SF-g-GMA conditions on day 7, chondrocyte cell vitality exceeded 80%. The PVA-g-GMA/SF-g-GMA 75:25 and 50:50 hydrogels hold promise as a biomimetic biphasic injectable hydrogel for encapsulated augmentation, offering advantages in terms of rapid photocurability, tunable mechanical properties, favorable biological responses, and controlled degradation.
polymer science
What problem does this paper attempt to address?
This paper aims to develop a biphasic injectable hydrogel for meniscal scaffolds. Specifically, the researchers prepared PVA - g - GMA and SF - g - GMA by modifying polyvinyl alcohol (PVA) and silk fibroin (SF) with glycidyl methacrylate (GMA). These modified polymers were used to prepare PVA - g - GMA/SF - g - GMA hydrogels in different ratios and solidify them by photocrosslinking techniques. The main objectives of the study include: 1. **Mechanical properties**: Evaluate the compressive modulus of PVA - g - GMA/SF - g - GMA hydrogels in different ratios. 2. **Morphology and pore size**: Observe the microstructure and pore size of the hydrogel. 3. **Biodegradability**: Test the degradation rate of the hydrogel under simulated physiological conditions. 4. **Cell compatibility**: Evaluate the cell survival rate and gene expression by mixing human chondrocyte cell lines (HCPCs) and encapsulating them in the hydrogel. Ultimately, the study hopes to develop a biphasic injectable hydrogel with rapid photocuring, adjustable mechanical properties, good biocompatibility, and controllable degradation characteristics for meniscal tissue engineering. This hydrogel has the advantages of minimally invasive delivery, biomimicry, biocompatibility, and personalized treatment in clinical applications.